REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US

被引：0
|
作者：
McCormack, Meredith C.
Noorduyn, Stephen G.
Gronroos, Noelle
Lee, Lydia
Johnson, Mary
Wrobleski, Kristin
Veeranki, Phani
Ismaila, Afisi S.
Igboekwe, Emmeline
Paczkowski, Rosirene
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3204
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4942A / 4943A
页数：2
相关论文
共 50 条
  • [31] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Wendt, A.
    Licht, B.
    Criee, C.
    PNEUMOLOGIE, 2023, 77 : S36 - S36
  • [32] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Nachtigall, D.
    Bogoevska, V
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S29 - S29
  • [33] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Trinkmann, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] REDUCTION OF ASTHMA EXACERBATIONS FOLLOWING INITIATION OF SINGLE-INHALER TRIPLE THERAPY WITH FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN US CLINICAL CARE
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Francois
    Mahendran, Malena
    Duh, Mei S.
    Dirocco, Kristi
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    Balkissoon, Ronald C.
    CHEST, 2023, 164 (04) : 6527A - 6528A
  • [35] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [36] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Koczulla, A.
    Akyildiz, B.
    Slawinska, R.
    Martini, M.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S35
  • [37] Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice
    Sansbury, Leah B.
    Bains, Chanchal
    Lipson, David A.
    Ismaila, Afisi S.
    Landis, Sarah H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1255 - 1264
  • [38] Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Real-World Predictive Model
    Bogart, M.
    Oakland, T.
    Liu, Y.
    Enev, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
    Lai, Chih-Cheng
    Chen, Cheng-Hsin
    Lin, Charlotte Yu Hsuan
    Wang, Cheng-Yi
    Wang, Ya-Hui
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 1539 - 1547
  • [40] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
12345